全文获取类型
收费全文 | 4074篇 |
免费 | 306篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 120篇 |
妇产科学 | 67篇 |
基础医学 | 535篇 |
口腔科学 | 67篇 |
临床医学 | 422篇 |
内科学 | 922篇 |
皮肤病学 | 49篇 |
神经病学 | 381篇 |
特种医学 | 201篇 |
外科学 | 648篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 211篇 |
眼科学 | 47篇 |
药学 | 358篇 |
中国医学 | 4篇 |
肿瘤学 | 318篇 |
出版年
2023年 | 26篇 |
2022年 | 37篇 |
2021年 | 103篇 |
2020年 | 63篇 |
2019年 | 105篇 |
2018年 | 119篇 |
2017年 | 81篇 |
2016年 | 95篇 |
2015年 | 114篇 |
2014年 | 157篇 |
2013年 | 177篇 |
2012年 | 307篇 |
2011年 | 281篇 |
2010年 | 173篇 |
2009年 | 152篇 |
2008年 | 252篇 |
2007年 | 255篇 |
2006年 | 262篇 |
2005年 | 243篇 |
2004年 | 210篇 |
2003年 | 228篇 |
2002年 | 220篇 |
2001年 | 18篇 |
2000年 | 22篇 |
1999年 | 29篇 |
1998年 | 49篇 |
1997年 | 45篇 |
1996年 | 29篇 |
1995年 | 23篇 |
1994年 | 18篇 |
1993年 | 17篇 |
1992年 | 18篇 |
1991年 | 15篇 |
1990年 | 12篇 |
1989年 | 18篇 |
1988年 | 27篇 |
1986年 | 15篇 |
1985年 | 20篇 |
1984年 | 15篇 |
1983年 | 18篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1978年 | 12篇 |
1977年 | 16篇 |
1976年 | 19篇 |
1975年 | 12篇 |
1973年 | 18篇 |
1965年 | 10篇 |
1964年 | 10篇 |
1960年 | 11篇 |
排序方式: 共有4411条查询结果,搜索用时 191 毫秒
991.
Wang SW Bertley FM Kozlowski PA Herrmann L Manson K Mazzara G Piatak M Johnson RP Carville A Mansfield K Aldovini A 《AIDS research and human retroviruses》2004,20(8):846-859
We explored the use of a simian-human immunodeficiency virus (SHIV) DNA vaccine as an effective mucosal priming agent to stimulate a protective immune response for AIDS prevention. Rhesus macaques were vaccinated rectally with a DNA construct producing replication-defective SHIV particles, and boosted with either the same DNA construct or recombinant modified vaccinia virus Ankara (MVA) expressing SIV Gag, SIV Pol, and HIV Env (MVA-SHIV). Virus-specific mucosal and systemic humoral and cell-mediated immune responses could be stimulated by this approach but were present inconsistently among the vaccinated animals. Rectal vaccination with either SHIV DNA alone or SHIV DNA followed by MVA-SHIV induced SIV Gag/Pol- or HIV gp120-specific IgA in rectal secretions of four of seven animals. However, the gp120-specific rectal IgA antibody responses were not durable and had become undetectable in all but one animal shortly before rectal challenge with pathogenic SHIV 89.6P. Only the macaques primed with SHIV DNA and boosted with MVA-SHIV demonstrated SHIV-specific IgG in plasma. In addition, these animals developed more consistent antiviral cell-mediated responses and had better preservation of CD4 T cells following challenge with SHIV 89.6P. Our study demonstrates the utility of a rectal DNA/MVA vaccination protocol for the induction of diverse responses in different immunological compartments. In addition, the immunity achieved with this mucosal vaccination regimen is sufficient to delay progression to AIDS. 相似文献
992.
Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene 总被引:5,自引:2,他引:5
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Inherited factor XI deficiency is an injury-related bleeding disorder that is rare in most populations except for Jews, in whom 2 mutations, a stop mutation in exon 5 (type II) and a missense mutation in exon 9 (type III), predominate. Recently, a cluster of 39 factor XI-deficient patients was described in the Basque population of Southwestern France. In this study, we determined the molecular basis of factor XI deficiency in 16 patients belonging to 12 unrelated families of French Basque origin. In 8 families, a nucleotide 209T>C transition in exon 3 was detected that predicts a Cys38Arg substitution. Four additional novel mutations in the factor XI gene, Cys237Tyr, Tyr493His, codon 285delG, and IVS6 + 3A>G, were identified in 4 families. Expression studies showed that Cys38Arg and Cys237Tyr factor XI were produced in transfected baby hamster kidney cells, but their secretion was impaired. Cells transfected with Tyr493His contained reduced amounts of factor XI and displayed decreased secretion. A survey of 206 French Basque controls for Cys38Arg revealed that the prevalence of the mutant allele was 0.005. Haplotype analysis based on the study of 10 intragenic polymorphisms was consistent with a common ancestry (a founder effect) for the Cys38Arg mutation. 相似文献
993.
Characterization of two patched receptors for the vertebrate hedgehog protein family 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
David Carpenter Donna M. Stone Jennifer Brush Anne Ryan Mark Armanini Gretchen Frantz Arnon Rosenthal Frederic J. de Sauvage 《Proceedings of the National Academy of Sciences of the United States of America》1998,95(23):13630-13634
The multitransmembrane protein Patched (PTCH) is the receptor for Sonic Hedgehog (Shh), a secreted molecule implicated in the formation of embryonic structures and in tumorigenesis. Current models suggest that binding of Shh to PTCH prevents the normal inhibition of the seven-transmembrane-protein Smoothened (SMO) by PTCH. According to this model, the inhibition of SMO signaling is relieved after mutational inactivation of PTCH in the basal cell nevus syndrome. Recently, PTCH2, a molecule with sequence homology to PTCH, has been identified. To characterize both PTCH molecules with respect to the various Hedgehog proteins, we have isolated the human PTCH2 gene. Biochemical analysis of PTCH and PTCH2 shows that they both bind to all hedgehog family members with similar affinity and that they can form a complex with SMO. However, the expression patterns of PTCH and PTCH2 do not fully overlap. While PTCH is expressed throughout the mouse embryo, PTCH2 is found at high levels in the skin and in spermatocytes. Because Desert Hedgehog (Dhh) is expressed specifically in the testis and is required for germ cell development, it is likely that PTCH2 mediates its activity in vivo. Chromosomal localization of PTCH2 places it on chromosome 1p33–34, a region deleted in some germ cell tumors, raising the possibility that PTCH2 may be a tumor suppressor in Dhh target cells. 相似文献
994.
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients 总被引:8,自引:0,他引:8
Belhadj K Reyes F Farcet JP Tilly H Bastard C Angonin R Deconinck E Charlotte F Leblond V Labouyrie E Lederlin P Emile JF Delmas-Marsalet B Arnulf B Zafrani ES Gaulard P 《Blood》2003,102(13):4261-4269
We report on the characteristics of 21 patients with hepatosplenic gammadelta T-cell lymphoma (HSgammadeltaTCL), an entity recognized since 1994 in the Revised European American Lymphoma (REAL) classification. Median age was 34 years. Patients had splenomegaly (n = 21), hepatomegaly (n = 15), and thrombocytopenia (n = 20). Histopathologic findings were homogeneous and showed the presence of medium-sized lymphoma cells within the sinusoids of splenic red pulp, liver, and bone marrow. Marrow involvement was usually mild but could be demonstrated by phenotyping in all patients. Cells were CD3+CD5-, expressed the gammadelta T-cell receptor, and had a nonactivated cytotoxic cell phenotype (TIA-1+, granzyme B-). Most patients were CD4-/CD8- (16 of 18); CD56+ (15 of 18), expressed the Vdelta1epitope (Vd1+/Vd2-/Vd3-) (9 of 12); and were negative for Epstein-Barr virus (EBV) (18 of 20). Isochromosome arm 7q was documented in 9 of 13 patients. Eight patients had previously undergone kidney transplantation or had a history of systemic lupus, Hodgkin disease, or malaria. Prognosis was poor; median survival time was 16 months, and all but 2 patients ultimately died despite consolidative or salvage high-dose therapy. In conclusion, HSgammadeltaTCL is a disease with distinctive clinical, histopathologic, and phenotypic characteristics. Bone marrow biopsy with combined phenotyping is sufficient for diagnosis, and splenectomy is therefore unwarranted. Current treatment modalities appear to be ineffective in most patients. 相似文献
995.
Mary Philip Sarkis Delcourt Julien Mancini Laetitia Tessonnier Serge Cammilleri Florent Arregle Hélène Martel Leopold Oliver Sandrine Hubert Sébastien Renard Laurence Camoin Anne Claire Casalta Jean Paul Casalta Frédérique Gouriet Alberto Riberi Hubert Lepidi Frederic Collart Didier Raoult Gilbert Habib 《Archives of Cardiovascular Diseases》2021,114(3):211-220
996.
997.
998.
Niklas Rommel Nils H. Rohleder Stefan Wagenpfeil Roland Härtel-Petri Frederic Jacob Klaus-Dietrich Wolff Marco R. Kesting 《Clinical oral investigations》2016,20(3):469-475
Objective
The use of methamphetamine (MA), a highly addictive stimulant, is rapidly increasing, with MA being widely abused as the scene drug “Crystal Meth” (CM). CM has been associated with severe oral health effects, resulting in so-called “Meth mouth”. This term appeared for the first time in 2005 in the literature and describes the final complex of symptoms including rampant caries, periodontal diseases and excessive tooth wear. The aim of this study was to investigate the effects of chronic CM abuse on teeth and intraoral tissue with respect to potential symptoms of Meth mouth.Materials and methods
In cooperation with two centres for addiction medicine, we performed clinical intraoral investigations in 100 chronic CM users and 100 matched-pair controls. We undertook a caries and periodontal examination by using the clinical parameters DMF-T/DMF-S, bleeding on probing index (BOP) and periodontal screening index (PSI) and tested individual oral hygiene by using approximal space plaque index (API). All clinical data were analysed by the t test for independent samples.Results
We found significantly larger numbers of caries (p < 0.001) and higher levels of gingival bleeding (p < 0.001) and periodontal disease (p < 0.001) among CM users. Oral hygiene was significantly lower in CM users (p < 0.024).Conclusion
Chronic CM use can lead to extensive potential damage within the intraoral cavity. When CM is used over a long period of time and in the absence of treatment, clinical symptoms in terms of Meth mouth syndrome cannot be excluded.Clinical relevance
Based on our results, we recommend a specific prevention and therapeutic concept including educational campaigns for MA users and specialized dental care for CM patients.999.
Vigyan Bang Sarju Ganatra Sachin P. Shah Sourbha S. Dani Tomas G. Neilan Paaladinesh Thavendiranathan Frederic S. Resnic Thomas C. Piemonte Ana Barac Rushin Patel Ajay Sharma Rohan Parikh Ghulam M. Chaudhry Mark Vesely Salim S. Hayek Monika Leja David Venesy Richard Patten Leslie T. Cooper 《Journal of the American College of Cardiology》2021,77(8):1122-1134
Giant cell myocarditis is a rare, often rapidly progressive and potentially fatal, disease due to T-cell lymphocyte-mediated inflammation of the myocardium that typically affects young and middle-aged adults. Frequently, the disease course is marked by acute heart failure, cardiogenic shock, intractable ventricular arrhythmias, and/or heart block. Diagnosis is often difficult due to its varied clinical presentation and overlap with other cardiovascular conditions. Although cardiac biomarkers and multimodality imaging are often used as initial diagnostic tests, endomyocardial biopsy is required for definitive diagnosis. Combination immunosuppressive therapy, along with guideline-directed medical therapy, has led to a paradigm shift in the management of giant cell myocarditis resulting in an improvement in overall and transplant-free survival. Early diagnosis and prompt management can decrease the risk of transplantation or death, which remain common in patients who present with cardiogenic shock. 相似文献
1000.
Masateru Takigawa Nicolas Derval Claire A. Martin Konstantinos Vlachos Arnaud Denis Takeshi Kitamura Ghassen Cheniti Felix Bourier Anna Lam Ruairidh Martin Antonio Frontera Nathaniel Thompson Grégoire Massoullié Michael Wolf Josselin Duchateau Nicolas Klotz Thomas Pambrun Frederic Sacher Pierre Jaïs 《Heart rhythm》2019,16(4):553-561